| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 117,0 k € | +21.8% | 96,1 k € | +7.6% | 89,3 k € | -8.2% | 97,2 k € | -5.5% | 102,8 k € | +20.4% | 85,4 k € | -5.3% | 90,2 k € | -0.1% | 90,3 k € | +7.5% | 84,0 k € | +11.0% | 75,6 k € | +17.3% | 64,5 k € | -6.1% | 68,7 k € | -1.9% | 70,0 k € | -2.7% | 71,9 k € | +51.9% | 47,3 k € | -33.1% | 70,8 k € | |
| EBITDA | 114,9 k € | +21.8% | 94,3 k € | +7.3% | 87,9 k € | -8.2% | 95,8 k € | -5.7% | 101,6 k € | +20.6% | 84,2 k € | -5.4% | 89,0 k € | -0.1% | 89,1 k € | +7.5% | 82,9 k € | +11.2% | 74,5 k € | +17.9% | 63,2 k € | -5.2% | 66,7 k € | -3.1% | 68,8 k € | -2.7% | 70,7 k € | +52.8% | 46,3 k € | -33.4% | 69,5 k € | |
| Operating profit | 97,0 k € | +27.0% | 76,4 k € | +10.0% | 69,4 k € | -9.7% | 76,9 k € | -4.5% | 80,5 k € | +30.8% | 61,5 k € | -7.9% | 66,8 k € | +0.8% | 66,3 k € | +8.0% | 61,4 k € | +25.5% | 48,9 k € | +24.8% | 39,2 k € | -7.0% | 42,2 k € | -8.1% | 45,9 k € | -4.4% | 48,0 k € | +60.9% | 29,8 k € | -40.5% | 50,1 k € | |
| Profit/loss | 80,6 k € | +28.4% | 62,8 k € | +15.9% | 54,2 k € | -7.5% | 58,6 k € | -3.7% | 60,8 k € | +33.3% | 45,7 k € | -6.2% | 48,7 k € | +12.1% | 43,4 k € | +10.8% | 39,2 k € | +42.1% | 27,6 k € | +48.7% | 18,6 k € | -10.0% | 20,6 k € | -10.0% | 22,9 k € | -6.9% | 24,6 k € | +223.5% | 7,6 k € | -65.6% | 22,1 k € | |
| Equity | 230,3 k € | +13.0% | 203,9 k € | +5.4% | 193,5 k € | +1.5% | 190,7 k € | +4.7% | 182,1 k € | +17.2% | 155,4 k € | +13.2% | 137,2 k € | +18.3% | 116,0 k € | +20.1% | 96,6 k € | +18.7% | 81,4 k € | +16.6% | 69,8 k € | +10.4% | 63,2 k € | +15.8% | 54,6 k € | +25.0% | 43,6 k € | +40.7% | 31,0 k € | +26.4% | 24,5 k € | |
| Total assets | 399,9 k € | +1.6% | 393,8 k € | -0.8% | 397,1 k € | -6.4% | 424,3 k € | -0.9% | 428,1 k € | +3.8% | 412,4 k € | -1.6% | 418,9 k € | +3.1% | 406,4 k € | +1.7% | 399,7 k € | +0.7% | 397,1 k € | +2.8% | 386,3 k € | -4.2% | 403,0 k € | +0.1% | 402,6 k € | -3.8% | 418,7 k € | +5.6% | 396,3 k € | -0.0% | 396,5 k € | |
| Cash | 23,2 k € | +187.3% | 8,1 k € | +249.4% | 2,3 k € | -79.5% | 11,2 k € | +14.0% | 9,9 k € | +65.9% | 5,9 k € | -65.3% | 17,1 k € | +18.5% | 14,5 k € | +694.1% | 1,8 k € | -67.0% | 5,5 k € | +51.0% | 3,7 k € | +104.7% | 1,8 k € | +44.4% | 1,2 k € | -83.8% | 7,6 k € | -66.3% | 22,7 k € | +118.9% | 10,4 k € | |
| Debts | 169,5 k € | -10.7% | 189,9 k € | -6.7% | 203,6 k € | -12.8% | 233,6 k € | -5.0% | 245,9 k € | -4.3% | 257,0 k € | -8.8% | 281,7 k € | -3.0% | 290,4 k € | -4.2% | 303,1 k € | -4.0% | 315,7 k € | -0.2% | 316,5 k € | -6.9% | 339,8 k € | -2.4% | 348,0 k € | -7.2% | 375,0 k € | +2.7% | 365,3 k € | -1.8% | 372,0 k € | |
Private company with limited liability · Boechout · incorporated on 19/09/2008
Private company with limited liability profitable and well capitalised. Cash position rising (+187.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. CASAER ELKE is a Private company with limited liability incorporated in 2008. Its main activity is: Specialist medical practice activities. Its registered office is in Boechout.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette